What is FAP Kdpharma Group
Par un écrivain mystérieux
Description
Familial Adenomatous Polyposis (FAP) is a hereditary condition that results in the early development of polyps and colorectal cancer that could starts at the early age of 12 years old. FAP is considered as an orphan disease, with a prevalence of 0,6/1,0 out of 10.000. Caused by germline mutations in the APC gene it is characterized by the development of hundreds to thousands of polyps and carriers of the APC gene mutation, if not treated appropriately, will develop colorectal cancer. Unfortunately at the moment there is no safe treatment available.
Leader in Pharmaceutical Omega 3 Manufacturing
Leader in Pharmaceutical Omega 3 Manufacturing
Leader in Pharmaceutical Omega 3 Manufacturing
Latest News < SLA Pharma AG
Justin Slagel on LinkedIn: #clinicaltrials #clinicalresearch
SLA Pharma
Fapon Biotech Inc.
Leader in Pharmaceutical Omega 3 Manufacturing
Promising fish oil-based coronavirus treatment heads to clinical
KD Pharma Group - capiton
KD Pharma Drug Master Files for their Omega-3
Fapon Biotech Inc.
KD Pharma
KD Pharma Group - capiton
depuis
par adulte (le prix varie selon la taille du groupe)